Correlation Between Sarofim Equity and Strategic Allocation

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sarofim Equity and Strategic Allocation at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarofim Equity and Strategic Allocation into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarofim Equity and Strategic Allocation Moderate, you can compare the effects of market volatilities on Sarofim Equity and Strategic Allocation and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarofim Equity with a short position of Strategic Allocation. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarofim Equity and Strategic Allocation.

Diversification Opportunities for Sarofim Equity and Strategic Allocation

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Sarofim and Strategic is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Sarofim Equity and Strategic Allocation Moderate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Strategic Allocation and Sarofim Equity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarofim Equity are associated (or correlated) with Strategic Allocation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Strategic Allocation has no effect on the direction of Sarofim Equity i.e., Sarofim Equity and Strategic Allocation go up and down completely randomly.

Pair Corralation between Sarofim Equity and Strategic Allocation

Assuming the 90 days horizon Sarofim Equity is expected to under-perform the Strategic Allocation. In addition to that, Sarofim Equity is 3.18 times more volatile than Strategic Allocation Moderate. It trades about -0.13 of its total potential returns per unit of risk. Strategic Allocation Moderate is currently generating about -0.1 per unit of volatility. If you would invest  683.00  in Strategic Allocation Moderate on November 29, 2024 and sell it today you would lose (27.00) from holding Strategic Allocation Moderate or give up 3.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Sarofim Equity  vs.  Strategic Allocation Moderate

 Performance 
       Timeline  
Sarofim Equity 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Sarofim Equity has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's primary indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.
Strategic Allocation 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Strategic Allocation Moderate has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong primary indicators, Strategic Allocation is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sarofim Equity and Strategic Allocation Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sarofim Equity and Strategic Allocation

The main advantage of trading using opposite Sarofim Equity and Strategic Allocation positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarofim Equity position performs unexpectedly, Strategic Allocation can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Strategic Allocation will offset losses from the drop in Strategic Allocation's long position.
The idea behind Sarofim Equity and Strategic Allocation Moderate pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format